Programme Overview
The scientific program covers the whole spectrum of nuclear medicine. Besides scientific sessions with proffered papers - these will be presented either orally or as posters - several special events are scheduled to discuss topics of interest.
The Gastein Lecture
Chair: P.A. Schubiger (Zurich)
- W. Weber (Freiburg):
PET/CT as tool for personalized therapy
The European Corner
Standardization of PET data: Intercomparison of images
- A. Bockisch (Essen):
Clinical aspects - a physician's view - R. Boellaard (Amsterdam):
Physical aspects - a physicist's view
Distinguished Pioneer´s Lecture
Chair: R. Höfer (Vienna)
- H. Mäcke (Freiburg):
Agonists or antagonists for peptide-based tumour imaging and radionuclide therapy?
Fireside Conference
- K.J. Langen (Juelich):
PET in neuro-oncology - B. Pichler (Tuebingen):
PET/MRI and the brain - K. Fraps (Munich):
PET: The magic of new concepts
Radionuclide Therapy
- H.J. Biersack (Bonn):
Selective Internal Radiation Therapy (SIRT) of liver malignancies - D.J. Kwekkeboom (Rotterdam):
How far are we from evidence in radiopeptide therapy?
Neurology/Psychiatry
- P. Dal Bianco (Vienna):
Dementias of old age - K. Herholz (Manchester):
Current developments in the imaging of dementia - S. Kasper (Vienna):
A beautiful mind - PET in psychiatry
Cardiology
- H. Schelbert (Los Angeles):
From microvessels to metabolism and remodelling - P.A. Kaufmann (Zurich)
New trends in myocardial perfusion imaging
Oncology
- J. Czernin (Los Angeles):
The cost (effectiveness) of cancer imaging - R. Wahl (Baltimore):
PERCIST: A new look at tumour response
MERCK Lunch Symposium
- M. Weissel (Vienna):
Thyroid and pregnancy - M. Raderer (Vienna):
New therapeutic trends in radioiodine-negative thyroid cancer patients
Radiopharmaceutical Sciences:
- S. Ametamey (Zurich):
PET radioligands for the glutamatergic system - H.H. Coenen (Juelich):
Benefits of PET-radiotracers for drug development - J. Steinbach (Dresden-Rossendorf):
Radiotracers for the cholinergic system
The Physicist's Corner
- M. Sámal (Prague):
Current concepts of quantitative renal imaging - A.E. Todd-Pokropek (London):
The place of 'quantitative' nuclear medicine in the administration of therapy
The Industry Corner
PET/MR as Low Dose PET/CT?
